Drug Shortage Report for XYLAC
| Report ID | 226445 |
| Drug Identification Number | 02230838 |
| Brand name | XYLAC |
| Common or Proper name | Xylac |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LOXAPINE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 tabs |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-04-29 |
| Actual start date | 2024-04-29 |
| Estimated end date | 2024-10-08 |
| Actual end date | 2024-10-10 |
| Shortage status | Resolved |
| Updated date | 2024-11-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v19 | 2024-11-14 | English | Compare |
| v18 | 2024-10-11 | French | Compare |
| v17 | 2024-10-11 | English | Compare |
| v16 | 2024-09-24 | French | Compare |
| v15 | 2024-09-24 | English | Compare |
| v14 | 2024-09-11 | French | Compare |
| v13 | 2024-09-11 | English | Compare |
| v12 | 2024-08-14 | French | Compare |
| v11 | 2024-08-14 | English | Compare |
| v10 | 2024-07-15 | French | Compare |
| v9 | 2024-07-15 | English | Compare |
| v8 | 2024-06-27 | French | Compare |
| v7 | 2024-06-27 | English | Compare |
| v6 | 2024-05-28 | French | Compare |
| v5 | 2024-05-28 | English | Compare |
| v4 | 2024-05-23 | English | Compare |
| v3 | 2024-04-30 | English | Compare |
| v2 | 2024-04-29 | French | Compare |
| v1 | 2024-04-29 | English | Compare |
Showing 1 to 19 of 19